Grants and Contracts per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Pediatric Endocrinology, Fellowship, University of Oklahoma Health Sciences Center
Jul 1 2012 → Jun 30 2015
Residency, Penn State Univ M Hershey Med Ct
2012
Doctor of Medicine, National and Capodistrian Univ
2008
Fingerprint
Dive into the research topics where Evangelia Kalaitzoglou is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration from the last 5 years on country level. Dive into details by clicking on the dots.
-
Muscle-bone Interaction and its Role in Diabetic Bone Disease of Type I Diabetes
Kalaitzoglou, E., Fowlkes, J., Kern, P. & Peterson, C.
National Institute Diabetes & Digestive & Kidney
3/1/21 → 12/31/25
Project: Research project
-
Myokines Involved in the TGF-Activing Signaling Pathway in Type 1 diabetes
Washington University in St. Louis
2/23/13 → 11/30/22
Project: Research project
-
The T1D Exchange Type 1 Diabetes Network
Thrailkill, K., Fowlkes, J., Kalaitzoglou, E. & Morales, A.
Jaeb Center for Health Research Foundation Incorporated
6/1/16 → 3/22/19
Project: Research project
-
TrialNet: Natural History Study of the Development of Type 1 Diabetes
Thrailkill, K., Fowlkes, J., Kalaitzoglou, E. & Morales, A.
4/18/16 → 9/9/20
Project: Research project
-
Diabetic Bone Disease and Diabetic Myopathy: Manifestations of the Impaired Muscle-Bone Unit in Type 1 Diabetes
Travis, C., Srivastava, P. S., Hawke, T. J. & Kalaitzoglou, E., 2022, In: Journal of Diabetes Research. 2022, 2650342.Research output: Contribution to journal › Review article › peer-review
Open Access -
Diabetic Bone Disease and Diabetic Myopathy: Manifestations of the Impaired Muscle-Bone Unit in Type 1 Diabetes
Travis, C., Srivastava, P. S., Hawke, T. J. & Kalaitzoglou, E., 2022, In: Journal of Diabetes Research. 2022, p. 2650342Research output: Contribution to journal › Review article › peer-review
-
Mouse models of type 1 diabetes and their use in skeletal research
Kalaitzoglou, E., Fowlkes, J. L. & Thrailkill, K. M., Aug 1 2022, In: Current Opinion in Endocrinology, Diabetes and Obesity. 29, 4, p. 318-325 8 p.Research output: Contribution to journal › Review article › peer-review
-
Mouse models of type 1 diabetes and their use in skeletal research
Kalaitzoglou, E., Fowlkes, J. L. & Thrailkill, K. M., Jun 27 2022, (E-pub ahead of print) In: Current Opinion in Endocrinology, Diabetes and Obesity.Research output: Contribution to journal › Article › peer-review
-
Canagliflozin, an SGLT2 inhibitor, corrects glycemic dysregulation in TallyHO model of T2D but only partially prevents bone deficits
Thrailkill, K. M., Bunn, R. C., Uppuganti, S., Ray, P., Popescu, I., Kalaitzoglou, E., Fowlkes, J. L. & Nyman, J. S., Dec 2020, In: Bone. 141, 115625.Research output: Contribution to journal › Article › peer-review
6 Scopus citations